Visceral hypersensitivity induced by stress is quite common in irritable bowel syndrome (IBS) patients. Probiotics play an important role in reducing visceral hypersensitivity in IBS patients. However, the mechanism has not been clearly elucidated. In this study, we investigated the role of nod-like receptor pyrin domain-containing protein 6 (NLRP6) in Clostridium butyricum-regulated IBS induced by stress. Our results showed that NLRP6 was down-regulated in IBS group colon tissues. In addition, IL-18, IL-1β, myeloperoxidase (MPO), D-lactic acid (D-LA), and CD172a were up-regulated in the IBS group of colonic mucous. IL-18 and IL-1β were also increased after the NLRP6 gene was silenced. Pathological score suggested low inflammation of colonic mucous rather than terminal ileum. Water-avoidance stress (WAS) showed visceral hypersensitivity to colonic distension. However, treatment with Clostridium butyricum reversed these results, exerting a beneficial effect. In conclusion, Clostridium butyricum may exert a beneficial action on visceral hypersensitivity of IBS by inhibiting low grade inflammation of colonic mucous through its action on NLRP6.
Introduction
Irritable bowel syndrome (IBS) is the most common type of functional gastrointestinal disease characterized by abdominal intermittent or continuous pain, abdominal discomfort, and changes in bowel evacuation habits. Brain-gut communication dysfunction, integrity of mucosa, and inflammation, as well as psychosocial factors, may play roles in IBS pathogenesis [1] . In recent years, more and more studies have revealed that IBS patients are also affected by low grade mucosal inflammation (LGMI) [2] . Gastrointestinal responses to stress include alterations in motility, visceral hypersensitivity, and intestinal permeability. In addition, psychosocial stress alters brain-gut interactions and may intensify a wide range of disorders, including IBS [3] .
Nod-like receptor pyrin domain-containing protein 6 (NLRP6) is the first member of the NLR protein family that inhibits the innate immune response-related signaling pathways [4] , thus inhibiting inflammation, promoting intestinal lesions healing, and modulating intestinal flora. A recent study [5] has shown that NLRP6 plays an important role in repairing intestinal mucosa, avoiding the spread of epithelial cell damage, and promoting goblet cell autophagy and mucus secretion, so as to maintain the stability of the intestinal internal environment. Furthermore, NLRP6 inflammasome plays a significant role in the intestinal flora and intestinal immune system. Indeed, chemical-induced colitis becomes more severe after NLRP6 silencing in mice and the intestinal flora composition is also significantly altered [6] . Healthy microbiota maintenance requires nucleotide binding oligomerization domain protein-like receptors, containing pyrin domain NLRP6 inflammasomes.
Alterations in the intestinal microbiota have been associated with IBS. IBS patients show a significant reduction in intestinal beneficial bacteria, such as latic acid bacteria and bifidobacteria, which disturb the balance of the normal intestinal microbiota, leading to bacterial infection, intestinal flora imbalance, and consequent disease [7] . Therefore, probiotics play an important role in supplementing normal intestinal flora, correcting flora imbalance and maintaining intestinal stability, significantly reducing intestinal sensitivity and restoring normal intestinal function in IBS patients. However, the mechanism of action of probiotics against intestinal sensitivity has not been clarified yet [8] .
Some studies [9, 10] have shown that LGMI could activate visceral hypersensitivity, which underlies that IBS and NLRP6 [11] inflammasome plays a significant role in inhibiting inflammation. Hence, the objective of this study was to investigate whether Clostridium butyricum could modulate visceral hypersensitivity, as well as to understand its effect on NLRP6 to evaluate the benefits of probiotic therapy. To reach the above goal, the expression of NLRP6 and its downstream factors, intestinal mucosa inflammation, and visceral hypersensitivity were evaluated in stress-associated gastrointestinal disorders. Overall, our results demonstrated that Clostridium butyricum might play a beneficial role in the visceral hypersensitivity of IBS by inhibiting LGMI through its action on NLRP6.
Materials and Methods

Animals and IBS mice model
Thirty C57BL/6 female mice (BK Experimental Animal Co., Ltd, Shanghai, China) weighing 15-20 g, 5-6 weeks old, were individually housed under controlled conditions (22°C ± 1°C, 65%-70% humidity) with a 12-h light/dark cycle for a week in the animal maintenance facility at the Zhejiang Chinese Medical University (Hangzhou, China). Water and food were provided ad libitum. All experimental protocols were performed according to the requirements of the China State Authority for Animal Research Conduct. Mice were randomly divided into three groups, eight mice per group: control group, IBS group, and Clostridium butyricum group. IBS group and Clostridium butyricum group mice were placed on a platform (3 × 3 × 6 cm) into a container (56 × 50 cm) containing approximately 5 cm of water (25°C) for 1 h daily (8 AM-9 AM, to decrease the circadian rhythmicity of sleep, thus modifying the nocturnal-diurnal difference) for 10 consecutive days [12] . The control group was not subject to any of these treatments. The Clostridium butyricum group received an intragastric administration of Clostridium butyricum (1.25 × 10 9 CFU/ml, 0.4 ml, provided by Shandong Kexing Bioproducts Co, Ltd, Jinan, China) once a day for 7 days, while the control and IBS groups were treated with an equal volume of saline once a day for the same number of days.
To evaluate colorectal distension (CRD), a cervical catheter balloon was slowly placed 2 cm into the mice rectum and secured by taping the attached tube to the tail. Mice underwent CRD at a pressure from 20 to 80 mm Hg for 20 s, with 4-min pause between distensions. Each measurement was taken five times to ensure accuracy.
The success of the model was determined by recording the abdominal withdrawal reflex (AWR). Using the semi-quantitative AWR test, mice AWR was evaluated as follows: 0, no behavioral response to CRD; 1, brief head movement only; 2, contraction of abdominal muscles; 3, abdomen lifting; 4, arching of the body and pelvis lifting. The stimulus intensity evoking visually identifiable contraction of the abdominal wall was recorded as CRD threshold intensity [13] .
Tissue and blood collection
Mice were euthanized after colorectal distension. Blood from the orbital venous plexus and tissues from the terminal ileum (2-3 cm length) and the colon close to the ileocecal portion (2-3 cm length) were collected under sterile conditions. Mice intestines were cut, washed with PBS to remove the fecal contents, opened longitudinally, placed immediately in 10% formaldehyde, and stored at room temperature or in liquid nitrogen at −80°C, respectively, until further use.
Cell culture and cell transfection
In order to determine the effect of NLRP6 inhibition on IL-18 and IL-1β, human epithelial colorectal adenocarcinoma cell Caco-2 (Cell Bank of the Chinese Academy of Sciences, Shanhai, China) was cultured in MEM with 10% fetal bovine serum (Gibco, Grand Island, USA) and 2 mM L-glutamine and incubated at 37°C, 5% CO 2 for 48 h in 6-well plates at 1 × 10 6 cells per ml per well. Next, Caco-2 cells were transiently transfected with NLRP6 siRNA (sense: GCAGAUUGGUUGCUGCGCA dTdT, antisense: UGCGCAGCAA CCAAUCUGC dTdT) and scrambled siRNA into 6-well plates using riboFECT™ CP transfection reagent (Ribobio, Guangzhou, China) according to the manufacturer's instruction. Cells transfected with scrambled siRNA were used as control. About 48 h after transfection, cells were collected from each well and subject to protein analysis and ELISA.
Western blot analysis
Western blot analysis was used to determine NLRP6, cysteinyl aspartate specific proteinase-1 (caspase-1), activating signal cointegrator (ASC), caspase recruitment domain 8 (CARD8), signal regulatory protein alpha (SIRP alpha, designated CD172a), interleukin-18 (IL-18), and interleukin-1 beta (IL-1β) expression in mice colon and terminal ileum tissue. In brief, protein samples were separated using 10% SDS-PAGE and transferred onto PVDF membranes. Membranes were blocked with 5% nonfat milk in PBS containing 0.1% Tween-20 (Sigma, St Louis, USA) at 4°C overnight under gentle rocking and incubated with primary antibodies at 4°C. Membranes were washed three times and probed with goat anti-rabbit secondary antibody (1:4000; Dawen, Hangzhou, China) for 2 h at room temperature. Immunoblots were visualized using an ECL detection kit (Amersham Biosciences, Pittsburgh, USA) and exposed to X-ray films. The primary antibodies (Abs) used in this study were as follows: rabbit polyclonal anti-mouse NLRP6 Ab (1:500; Sigma); rabbit monoclonal anti-Caspase-1 Ab 
RT-PCR
Total RNA was extracted from tissues and cells using Takara Minibest Universal RNA Extraction kit (Takara, Dalian, China) following the manufacturer's instructions. PrimeScript™RT Master mix (Takara) was used for reverse transcription reactions with 0.5 μg of total RNA. Amplification was performed on a GeneAmp PCR system (Bio-Rad Laboratories, Hercules, USA). Quantitative polymerase chain reaction (qPCR) solution contained 5 μl of 2×SYBR Premix Ex Taq II (Takara), 0.4 μl of each PCR primer (Sangon, Shanghai, China) designed by Primer Premier 6.0 and Beacon designer 7.8 software ( Table 1) , 0.2 μl of Rox reference dye, 1 μl of cDNA template, and 3 μl of dH 2 O, for a total of 10 μl reaction volume. Cycling conditions were as follows: predenaturation at 95°C for 30 s, followed by 40 cycles consisting of denaturation at 95°C for 5 s and annealing at 60°C for 34 s, and eventually into the dissociation stage. Each sample was measured three times and RNA relative expression was calculated using the 2 −ΔΔCt method.
Immunohistochemistry assay
Mice paraffin-embedded intestines were cut into 4-μm thick sections, mounted on gelatin-coated slides, and heated at 60°C for 2 h. Paraffin was removed by an automatic dyeing machine program and samples were rehydrated. To heat repair the antigen, tissue sections were soaked in citrate buffer (0.01 M, pH 6.0) for 3 min until cooling. Endogenous peroxidase activity was blocked using 3% hydrogen peroxidase solution for 10-15 min, then the slides were washed and incubated with goat polyclonal anti-NLRP6 Ab (1:500; Santa Cruz, Santa Cruz, USA) in complete medium overnight at 4°C. The slides were rinsed with 0.01 M PBS three times for 5 min. Next, sections were incubated with secondary Ab donkey anti-goat IgG (H+L) (Abcam, Cambridge, UK) at 37°C for 1 h, followed by three times of wash with 0.01 M PBS for 5 min. DAB developing solution was used for 1-20 min to stain the slides. Sections were dehydrated in a graded alcohol series, and covered with a cover slip. Five fields at high magnification were randomly selected from the images of each mouse intestinal tissue and the average integral optical density value (IOD/Area) was calculated, reflecting the expression of the corresponding protein.
Hematoxylin and eosin staining
Mice paraffin-embedded intestines were cut into 5-μm thick sections. Hematoxylin and eosin (H&E) staining was performed using a standard protocol. The colon and terminal ileum mucosal pathology score was evaluated as follows [14] : cryptal architecture changes, 3-6 points; number of round-cell infiltrates in the lamina propria mucosae, 0-3 points; goblet cell death, 1 point; submucosal fibrous tissue hyperplasia, 1 point; granuloma, 1 point. Total score: 0: inflammation, 1-4: low inflammation, 5-8: inflammation, 9-12: severe inflammation.
ELISA
Blood was collected from the orbital venous plexus, while Caco-2 cells were transfected with NLRP6 siRNA as described in the above. Both blood and cell samples were centrifuged at low temperature. The concentration of IL-18, IL-1β, myeloperoxidase (MPO), D-lactic acid (D-LA) (all of them in serum and only IL-18 and IL-1β in cell samples) was measured using commercially available ELISA kits (Xitang Biological Technology Company, Shanghai, China). The OD value was measured on a microplate reader and sample concentration was obtained using a standard curve. Samples were assayed in duplicate according to the product specification.
Statistical analysis
Statistical analyses were performed using SPSS19.0 software. Data were expressed as mean ± SD and compared using the independent samples t-test after determination of normal distribution and equal variance. Mann-Whitney U was performed for rating information. P < 0.05 was considered statistically significant. Figure 1 . AWR scores at pressure from 20 to 80 mm Hg IBS group intestinal sensitivity increased significantly compared with the control group, as shown by the enhanced degree of abdominal contractions (*P < 0.05). The degree of abdominal contraction was remarkably lower in the Clostridium butyricum group compared with the IBS group (*P < 0.05), and the intestinal sensitivity was decreased after seven continuous days of intragastrical Clostridium butyricum adminstration. n.s. P > 0.05.
Results
Reliability of the IBS model
The AWR score of the IBS group was significantly higher than that of the control group at 20, 40, and 60 mm Hg pressure dilation (P < 0.05; Fig. 1 and Table 2 ), while no difference was observed between the two groups at 80 mm Hg ( Fig. 1 and Table 2 ). This result was indicative of visceral hypersensitivity in the IBS model mice; therefore the IBS model was successfully established. The AWR score of the Clostridium butyricum group was lower than that of the IBS group at 20, 40, and 60 mm Hg pressure dilation (P < 0.05; Fig. 1 and Table 2 ), suggesting that Clostridium butyricum could effectively reduce the degree of intestinal sensitivity and restore intestinal physiological function.
Expression of NLRP6 inflammasomes, CD172a, IL-18, and IL-1β protein NLRP6 protein expression was remarkably decreased in the colon of IBS group mice compared with control group (0.55 ± 0.06 and 1.00 ± 0.08, respectively, P < 0.05). CD172a, IL-18, and IL-1β protein expressions were increased in the colon of IBS group mice at the same time (1.52 ± 0.18 vs. 1.00 ± 0.12, 1.83 ± 0.22 vs. 1.00 ± 0.16, and 1.70 ± 0.21 vs. 1.00 ± 0.09, respectively, P < 0.05), while no difference was observed in Caspase-1, ASC, and CARD8 protein expressions between the above groups ( Fig. 2 and Table 3 ). However, NLRP6 expression was higher in the Clostridium butyricum group than that in the IBS group (0.81 ± 0.09 vs. 0.55 ± 0.06, P < 0.05). Meanwhile, CD172a, IL-18, and IL-1β protein expressions were decreased in the Clostridium butyricum group (Fig. 2 and Table 3 ). NLRP6 protein expression in the terminal ileum of IBS group mice was increased compared with that in the control group (1.83 ± 0.16 vs. 1.00 ± 0.06, P < 0.05; Fig. 3 and Table 3 ). NLRP6, Caspase-1, and ASC protein expressions were significantly decreased after the NLRP6 gene was silenced compared with the blank group (P < 0.05; Fig. 4 ), which implied a successful transfection.
Expression of NLRP6 inflammasomes RNA
The expressions of NLRP6, Caspase-1, and ASC mRNA did not show any significant difference after stress exposure ( Table 4 ). In addition, no significant difference was observed between the Clostridium butyricum group and IBS group in the colon tissue ( Table 4) . According to the above results, we could deduce that NLRP6 gene expression was regulated at the translation level.
Expression of NLRP6 in colon and terminal ileum mucosa
The number of NLRP6-positive cells in the colon mucous layer was significantly lower in the IBS group mice than in the control group mice (0.22 ± 0.01 vs. 0.31 ± 0.01, P < 0.01; Fig. 5 and Table 5 ), while it was higher in the Clostridium butyricum group mice than in the IBS group mice (0.29 ± 0.01 vs. 0.22 ± 0.01, P < 0.01; Fig. 5 and Table 5 ). However, NLRP6 expression in the terminal ileum mucous layer of IBS group mice was increased compared with that in the control group mice (0.36 ± 0.02 vs. 0.30 ± 0.01, P < 0.01; Table 5 ), and Clostridium butyricum did not work when compared with IBS group (0.34 ± 0.02 vs. 0.36 ± 0.02, Table 5 ).
Pathological changes in colon and terminal ileum mucosa
Pathological analysis of colon segments from IBS group mice revealed low grade mucosal inflammation (LGMI; Fig. 6B ). In contrast, control group mice showed normal pathology (Fig. 6A) . Pathology score in IBS group was 1.25 ± 0.16, and in the control group was 0.38 ± 0.18, which showed significant difference (P < 0.01; Table 6 ). After Clostridium butyricum treatment, inflammatory cell infiltration in mice was alleviated (P < 0.01; Fig. 6C and Table 6 ). However, mice terminal ileum in the IBS group did not show any change in inflammatory cells infiltration compared with that in the control group (P > 0.05; Table 6 ).
Expression of downstream cytokines in cell supernatant and mice serum
IL-1β and IL-18 protein levels in Caco-2 cell supernatant was 126.70 and 155.30 pg/ml, respectively, in the NLRP6 silencing group, while it was 73.94 and 88.55 pg/ml, respectively, in the control group, which showed significant difference for both proteins (P < 0.05; Table 7 ). IL-1β, IL-18, MPO, and D-LA protein expressions in serum between the control and IBS groups were statistically different (P < 0.05; Table 7 ). Serum IL-1β, IL-18, D-LA, and MPO levels were lower in the Clostridium butyricum group than in the IBS group (all P < 0.05; Table 7 ).
Disscussion
IBS is considered as a brain-intestinal axis of physiological regulation disorders disease. It reflects a connection between brain and intestine, since brain stress can aggravate intestinal disorders due to IBS. Chadwick et al. [15] found that 40% IBS patients' colorectal biopsy specimens showed non-specific inflammatory manifestations, such as neutrophils, mast cells and T cell infiltration, indicating IBS patients with intestinal mucosal inflammation. It is often referred to as low inflammation. Visceral hypersensitivity is one of the characteristics of IBS [16] . It has also been shown that low grade inflammation of mucous can activate visceral hypersensitivity, which is quite common in IBS patients, and it is considered to play vital roles in IBS pathogenesis [10] .
Consistent with a previous study [17] , this study also showed that WAS in mice induced visceral hypersensitivity to colonic distension, which is an IBS pathologic feature. In addition, intestinal flora disorders were found in both IBS patients and animal models. Kassinen et al. [18] discovered that the number of Lactobacillus and Bifidobacterium was decreased in the stool of IBS patients, while the amount of facultative anaerobic bacteria, mainly Streptococcus and Escherichia coli, is increased. Intestinal microflora plays an important role in maintaining intestinal stability, reducing intestinal sensitivity in IBS patients and restoring normal intestinal function significantly, but its mechanism has not been clarifyied yet.
NLRP6 is the upstream regulatory factor in transferring inflammatory signaling and can connect Caspase-1, ASC and CARD8 to form NLRP6 inflammasome through the function of protein-protein junction of the N-terminal PYD domain [19, 20] , which can negatively regulate the NF-κB and MAPK signaling pathways [21] , adjust and control cells to produce IL-1β, IL-18 and other cytokines [22, 23] involved in the inflammatory response and innate immune response. NLRP6 inflammasome plays a vital role in restraining the inflammatory response, promoting intestinal mucosal repair, and preventing the occurrence of intestinal tumors, and is involved in the anti-bacterial immune response. NLRP6-deficient mice showed an inhibition in the activation of NF-κB and MAPK, resulting in apoptosis promotion and inflammation inhibition [4, 24] . So far, studies on the relationship between Clostridium butyricum and NLRP6 in IBS visceral hypersensitivity induced by stress are still lacking. In this study, we reported that Clostridium butyricum might play a beneficial role in visceral hypersensitivity of IBS by inhibiting low grade inflammation of colonic mucous through its action on NLRP6.
Our present results showed that NLRP6 expression in the IBS group colon was lower than that in the control group, while its ligand Caspase-1, ASC, and CARD8 showed no significant change, indicating that NLRP6 protein was mainly involved in IBS. This study also disclosed that the level of IL-18 and IL-1β, downstream NLRP6 signaling pathway factors, was up-regulated in the IBS group, which was consistent with existing research [25, 26] . The higher IL-18 and IL-1β level after NLRP6 gene silencing confirmed the correlation between NLRP6 and IL-18 and IL-1β. CD172a expression, which represented the inflammation degree was increased in the colon mucosa of IBS group. The pathological score suggested low inflammation in colonic mucous, and mice visceral hypersensitivity in the IBS group was higher than that in the control group. We propose that the absence of colon NLRP6 due to WAS may lead to the up-regulation of its downstream effectors IL-18 and IL-1β, resulting in low inflammation of colonic mucous, thus causing high visceral hypersensitivity in IBS.
It is worth mentioning that the expression of NLRP6 inflammasomes in the terminal ileum of IBS mice was increased, which is consistent with a previous study by Hou et al. [27] . H&E staining revealed unconspicuous inflammation, with no clear change in IL-18 and IL-1β concentration, indicating that IBS low grade inflammation occurred in the colon rather than the terminal ileum. We hypothesize that the small intestine has a self-adjusting function in response to stress, which might lead to the increase in NLRP6 expression, so that IL-18 and IL-1β secretion remained in equilibrium, thus weakening the ileal inflammatory response. However, more experiments and investigations are needed to confirm this hypotesis.
Probiotics can alleviate IBS symptoms effectively, which may be related to the regulation of intestinal flora, intestinal inflammatory factors, and visceral hypersensitivity [27, 28] . Clostridium butyricum affects the intestinal immune homeostasis through regulating the intestinal mucosa Treg cell differentiation. The fermentation product of butyric acid has anti-inflammatory beneficial effects on epithelial cells [29] . This is consistent with our results showing a reducition of intestinal inflammation after Clostridium butyricum treatment. D-LA is the metabolite of bacterial fermentation that reflects intestinal mucosal epithelial cell permeability and intestinal barrier function. Samira et al. [30] found that MPO is elevated in IBS patients with colonic mucosal pathological changes. Thus, MPO level is one of the indicator of peroxidation and inflammation in the intestinal mucosa.
Our research revealed that NLRP6 expression was increased, while the levels of IL-18 and IL-1β were remarkably decreased in the colon mucosa of Clostridium butyricum group. Furthermore, we also found that the levels of D-LA, MPO, CD172a in Clostridium butyricum group were decreased and inflammatory infiltration in the colonic mucosal layer was reduced. Mice visceral hypersensitivity in the Clostridium butyricum group was also significantly lower than that in the IBS group, implying that Clostridium butyricum could promote NLRP6 protein expression, further down-regulate the expressions of IL-18 and IL-1β, and inhibit the inflammation to restore the intestinal mucosal barrier function, thus regulating the visceral hypersensitivity of IBS mice. In summary, our findings provided evidence that NLRP6 is involved in IBS pathogenesis. Exposure to stress may inhibit NLRP6 expression and alter the composition of the gut microbiota, leading to intestinal inflammation. Persistent low levels of inflammation may increase intestinal visceral sensitivity, while treatment with Clostridium butyricum may reverse these results, exerting a beneficial effect.
An increased attention is nowadays paid on the role of inflammatory factors and intestinal microecology in functional gastrointestinal diseases. As an immune-related gene, NLRP6 acts as a 'guard' in inducing intestinal bacterial products or cell damage, which can regulate the production of IL-18, IL-1β to inhibit intestinal inflammation and prevent intestinal microecological imbalance. In conclusion, our findings might explain the benefits of probiotics, especially Clostridium butyricum, in patients with stress-associated gastrointestinal disorders. Confirmation of a causal relationship between NLRP6 and visceral sensitivity in IBS patients may further validate the clinical use of probiotics to treat IBS. Our results suggest that NLRP6 may be an important target in the development of a novel therapy against stressed-induced intestinal disorders. 
